Skip to content

Blogs

Suraksha IPO Allotment Status & GMP: Your Key to Big Profits

The Suraksha Diagnostic IPO is set to open on November 29, 2024, with a price band of ₹420 to ₹441 per share and a target to raise ₹846.25 crores through a complete offer-for-sale (OFS) of 1.92 crore shares. The IPO will close on December 3, 2024, with the Suraksha IPO allotment status available on December 4, 2024, and the listing date set for December 6, 2024. Investors can subscribe with a minimum lot size of 34 shares, requiring a minimum investment of ₹14,994. Currently, there is no Suraksha IPO GMP today, reflecting low… Read More »Suraksha IPO Allotment Status & GMP: Your Key to Big Profits

Swiggy Share Price Target 2024-2030: Parent Company & Predictions for Big Returns in India

Swiggy’s share price target has sparked considerable interest, with analysts offering varying forecasts. Currently priced at ₹458, Swiggy’s stock has risen by 6.2% recently, signaling positive momentum. UBS has set a target of ₹515, projecting a 20% upside, while Macquarie offers a more conservative target of ₹325 due to profitability concerns. For 2025, predictions vary from ₹470 to ₹680, while for 2030, the target could range from ₹928 to ₹1125, depending on market conditions and operational success. These targets reflect Swiggy’s growth potential amidst competitive challenges in the food delivery sector. Swiggy Share… Read More »Swiggy Share Price Target 2024-2030: Parent Company & Predictions for Big Returns in India

Marksans Pharma Share Price Target: ₹550, 2024-2040 Projections, Latest News & Profitable Investment Insights

Marksans Pharma is a promising name in the pharmaceutical industry, with its share price target for 2025 set at ₹550. This target reflects the company’s robust growth strategies, which include technological advancements, market expansion, and product diversification. Backed by its financial performance and innovative approaches, Marksans Pharma share price target 2025 excites investors looking for strong returns. Marksans Pharma Share Price Target 2024: A Stepping Stone to ₹400 The Marksans Pharma share price target 2024 is expected to reach ₹400, showing steady growth from its current… Read More »Marksans Pharma Share Price Target: ₹550, 2024-2040 Projections, Latest News & Profitable Investment Insights

× How can I help you?
×